Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 A, 2009, Pages 2888-2898

  Lin, Xiu Ying ^a   He, Chun Di ^a   Xiao, Ting ^a   Jin, Xin ^a   Chen, Jiang ^a   Wang, Ya Kun ^a   Liu, Mei ^a   Wang, Kai Bo ^a   Jiang, Yi ^a   Wei, Hua Chen ^b   Chen, Hong Duo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Death receptor CD95 apoptosis pathway; Retinoid; SCC

Indexed keywords

CASPASE; ETRETIN; FADD PROTEIN, HUMAN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FAS PROTEIN, HUMAN; MESSENGER RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ACITRETIN; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 72849118198     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00397.x     Document Type: Article

References (39)

1. Jagdeo J, Weinstock MA, Piepkorn M, et al. Reliability of the histopathologic diagnosis of keratinocyte carcinomas. J Am Acad Dermatol. 2007 57 : 279 284.
2. Kovach BT, Murphy G, Otley CC, et al. Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey. Transplant Proc. 2006 38 : 1366 1368.
3. Carneiro RV, Sotto MN, Azevedo LS, et al. Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans cells in sun exposed and sun protected skin. Clin Transplant. 2005 19 : 115 121.
4. Cheepala SB, Syed Z, Trutschl M, et al. Retinoids and skin: microarrays shed new light on chemopreventive action of all-trans retinoic. Acid Mol Carcino. 2007 46 : 634 639.
5. Lebwohl M, Tannis C, Carrasco D. Acitretin suppression of squamous cell carcinoma case report and literature review. J Dermatol Treat. 2003 14 : 3 6.
6. Kuan YZ, Hsu HC, Kuo TT, et al. Multiple verrucous carcinomas treated with acitretin. J Am Acad Dermatol. 2007 56 : 29 32.
7. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg. 2004 30 : 656 661.
8. Reilly P, DiGiovanna JJ. Retinoid chemoprevention in high-risk skin cancer patients. Dermatol Nurs. 2004 16 : 117 120.
9. Orlandi A, Bianchi L, Costanzo A, et al. Evidence of increased apoptosis and reduced proliferation in basal cell carcinoma treated with tazarotene. J Invest Dermatol. 2004 122 : 1037 1041.
10. Harwood CA, Leedham-Green M, Leigh IM, et al. Low dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol. 2005 141 : 456 464.
11. Schule R, Rangarajan P, Yang N, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA. 1991 88 : 6092 6096.
12. Hansen LA, Sigman CC, Andreola F, et al. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis. 2000 21 : 1271 1279.
13. Wright TI, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol. 2006 54 : 933 946.
14. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 2005 5 : 231 237.
15. Barnhart BC, Alappat EC, Peter ME. The CD95 type I/type II model. Semin Immunol. 2003 15 : 185 193.
16. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ. 2003 10 : 26 35.
17. Scaffidi C, Fulda S, Srinivasan, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998 17 : 1675 1687.
18. Chun KH, Pfahl M, Lotan R. Induction of apoptosis by the synthetic retinoid MX3350-1 through extrinsic and intrinsic pathways in head and neck squamous carcinoma cells. Oncogene. 2005 24 : 3669 3677.
19. Hengartner, MO. The biochemistry of apoptosis. Nature. 2000 407 : 770 776.
20. Xian M, Ito K, Nakazato T, et al. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway. Cancer Sci. 2007 98 : 118 126.
21. Tilgen W, Boukamp P, Breitkreutz D, et al. Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res. 1983 43 : 5995 6011.
22. Schön MP, Schön M, Klein CE, et al. Carcinoma-associated 38-kD membrane glycoprotein MH 99/KS 1/4 is related to proliferation and age of transformed epithelial cell lines. J Invest Dermatol. 1994 102 : 987 991.
23. Boukamp P, Petrussevska RT, Breitkreutz D, et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 1998 106 : 761 771.
24. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997 91 : 443 446.
25. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998 281 : 1312 1316.
26. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 1999 68 : 383 424.
27. Kim SG, Jong HS, Kim TY, et al. Transforming growth factor-β1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol Biol Cell. 2004 15 : 420 434.
28. Jung JY, Kim WJ. Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells. Neurosci Lett. 2004 371 : 85 90.
29. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice, Nature. 1996 384 : 368 372.
30. Park MT, Kang JA, Choi JA, et al. Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells. Clin Cancer Res. 2003 9 : 878 885.
31. Ito K, Nakazato T, Murakami A, et al. Induction of apoptosis in human myeloid leukemic cells by 1'-acetoxychavicol acetate through a mitochondrial- and Fas-mediated dual mechanism. Clin Cancer Res. 2004 15 : 2120 2130.
32. Zou H, Li Y, Liu X, et al. An APAF-1. Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999 274 : 11549 11556.
33. Poulaki V, Mitsiades N, Romero ME, et al. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and bcl-2. Cancer Res. 2001 61 : 4864 4872.
34. Henkler F, Behrle E, Dennehy KM, et al. The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol. 2005 168 : 1087 1098.
35. Filipowicz E, Adegboyega P, Sanchez RL, et al. Expression of CD95 (FAS) in Sun-Exposed Human skin and cutaneous carcinomas. Am Cancer Soc. 2002 94 : 814 819.
36. de Sévaux RG, Smit JV, de Jong EM, et al. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol. 2003 49 : 407 412.
37. Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol. 2005 152 : 518 523.
38. Kovach BT, Sams HH, Stasko T. Systemic strategies for chemoprevention of skin cancers in transplant recipients. Clin Transplant. 2005 19 : 726 734.
39. Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind placebo controlled study. J Clin Oncol. 1995 13 : 1933 1938.